Cost effectiveness of retreatment with consensus interferon for chronic hepatitis C.

被引：0
|
作者：
McHutchison, JG
Woolley, JM
Nyberg, LM
机构：
[1] SCRIPPS CLIN,LA JOLLA,CA 92037
[2] AMGEN INC,THOUSAND OAKS,CA 91320
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1171 / 1171
页数：1
相关论文
共 50 条
  • [31] Successful retreatment of chronic hepatitis C patients with a nonresponse to standard interferon/ribavirin using daily consensus interferon and ribavirin.
    Kaiser, S
    Hass, H
    Gregor, M
    HEPATOLOGY, 2004, 40 (04) : 240A - 240A
  • [32] Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    Emmett, C
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [33] RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION WITH CONSENSUS INTERFERON - RESULTS OF A MAINTENANCE STUDY
    TONG, MJ
    BLATT, LM
    KLEIN, M
    MANYAK, C
    POULAKOS, J
    SAYADZADEH, K
    GASTROENTEROLOGY, 1995, 108 (04) : A1188 - A1188
  • [34] Successful retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
    Kaiser, S
    Hass, H
    Gregor, M
    GASTROENTEROLOGY, 2004, 126 (04) : A668 - A668
  • [35] Successful Retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy
    Kaiser, S
    Hass, H
    Gregor, M
    GASTROENTEROLOGY, 2003, 124 (04) : A700 - A700
  • [36] The role of genotyping in cost-effectiveness of interferon and ribavirin for chronic hepatitis C
    Younossi, ZM
    Singer, ME
    Shermock, KM
    McHutchison, JG
    GASTROENTEROLOGY, 1999, 116 (04) : A1293 - A1293
  • [37] Cost effectiveness of interferon or peginterferon with ribavirin for histologically mild chronic hepatitis C
    Grieve, R.
    Roberts, J.
    Wright, M.
    Sweeting, M.
    DeAngelis, D.
    Rosenberg, W.
    Bassendine, M.
    Main, J.
    Thomas, H.
    GUT, 2006, 55 (09) : 1332 - 1338
  • [38] Predictors of response to interferon in chronic hepatitis C.
    Mollison, L
    Totten, L
    Olynyk, J
    Greenfield, C
    Beaman, M
    HEPATOLOGY, 1998, 28 (04) : 710A - 710A
  • [39] Combination therapy with interferon α and β to chronic hepatitis C.
    Horilke, N
    Michitaka, K
    Masumoto, T
    Yamamoto, K
    Yamauchi, Y
    Kojima, N
    Onjl, M
    HEPATOLOGY, 1998, 28 (04) : 373A - 373A
  • [40] Cost-effectiveness of ribavirin and pegylated interferon alfa-2b for initial treatment of chronic hepatitis C.
    Wong, JB
    Siebert, U
    Manns, MP
    McHutchison, JG
    Sroczynski, G
    Wasem, J
    Ravens-Sieberer, U
    Rossol, S
    Ling, MH
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 691A - 691A
12345